<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e> (pSS) is a <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> with symptoms and serological findings often overlapping with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) (1) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001907'>Thromboembolic events</z:hpo> are common in SLE but not in pSS (2)(3) </plain></SENT>
<SENT sid="2" pm="."><plain>However, case reports have described pSS patients who developed fulminant multiorgan disease due to thrombotic diathesis 4, and we have presented a case with <z:hpo ids='HP_0011009'>acute</z:hpo> catastrophic anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS) in a pSS patient (5) </plain></SENT>
<SENT sid="3" pm="."><plain>In this study we wanted to examine the incidence of thromboembolic episodes and relate these to the presence of autoantibodies and <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo> in 90 pSS patients during a 4.6-year follow-up </plain></SENT>
</text></document>